Gluskin Sheff & Assoc Inc Zoetis Inc. Transaction History

Gluskin Sheff & Assoc Inc

  • $797 Million
  • Q4 2024

A detailed history of Gluskin Sheff & Assoc Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 7,106 shares of ZTS stock, worth $1.15 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
7,106
Previous 9,954 28.61%
Holding current value
$1.15 Million
Previous $1.94 Million 40.48%
% of portfolio
0.15%
Previous 0.24%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$162.24 - $194.42 $462,059 - $553,708
-2,848 Reduced 28.61%
7,106 $1.16 Million
Q2 2024

Aug 14, 2024
SELL
$145.54 - $178.83 $15,572 - $19,134
-107 Reduced 1.06%
9,954 $1.73 Million
Q1 2024

May 15, 2024
SELL
$165.67 - $199.94 $325,044 - $392,282
-1,962 Reduced 16.32%
10,061 $1.7 Million
Q4 2023

Feb 14, 2024
SELL
$151.44 - $200.09 $555,179 - $733,529
-3,666 Reduced 23.37%
12,023 $2.37 Million
Q3 2023

Nov 14, 2023
SELL
$167.14 - $192.77 $339,294 - $391,323
-2,030 Reduced 11.46%
15,689 $2.73 Million
Q2 2023

Aug 14, 2023
SELL
$160.94 - $186.23 $436,791 - $505,428
-2,714 Reduced 13.28%
17,719 $3.05 Million
Q1 2023

May 15, 2023
SELL
$145.48 - $175.02 $224,330 - $269,880
-1,542 Reduced 7.02%
20,433 $3.4 Million
Q4 2022

Feb 14, 2023
BUY
$131.14 - $157.47 $29,113 - $34,958
222 Added 1.02%
21,975 $3.22 Million
Q3 2022

Nov 14, 2022
SELL
$148.29 - $182.55 $31,734 - $39,065
-214 Reduced 0.97%
21,753 $3.23 Million
Q2 2022

Aug 15, 2022
SELL
$155.97 - $200.09 $36,496 - $46,821
-234 Reduced 1.05%
21,967 $3.78 Million
Q1 2022

May 16, 2022
SELL
$181.39 - $234.03 $12,697 - $16,382
-70 Reduced 0.31%
22,201 $4.19 Million
Q4 2021

Feb 14, 2022
BUY
$193.69 - $247.03 $41,643 - $53,111
215 Added 0.97%
22,271 $5.44 Million
Q3 2021

Nov 12, 2021
BUY
$189.29 - $209.69 $6,246 - $6,919
33 Added 0.15%
22,056 $4.28 Million
Q2 2021

Aug 13, 2021
BUY
$155.9 - $187.99 $12,160 - $14,663
78 Added 0.36%
22,023 $4.1 Million
Q1 2021

May 14, 2021
SELL
$144.0 - $169.39 $7,920 - $9,316
-55 Reduced 0.25%
21,945 $3.46 Million
Q4 2020

Feb 16, 2021
BUY
$157.07 - $174.35 $1,256 - $1,394
8 Added 0.04%
22,000 $3.64 Million
Q3 2020

Nov 12, 2020
SELL
$137.1 - $165.37 $49,356 - $59,533
-360 Reduced 1.61%
21,992 $3.64 Million
Q2 2020

Aug 11, 2020
SELL
$111.92 - $142.53 $187,130 - $238,310
-1,672 Reduced 6.96%
22,352 $3.06 Million
Q1 2020

May 13, 2020
BUY
$92.66 - $144.94 $29,095 - $45,511
314 Added 1.32%
24,024 $2.83 Million
Q4 2019

Feb 12, 2020
SELL
$116.25 - $133.25 $18,367 - $21,053
-158 Reduced 0.66%
23,710 $3.07 Million
Q3 2019

Nov 08, 2019
BUY
$112.57 - $128.43 $2.69 Million - $3.07 Million
23,868 New
23,868 $2.97 Million

Others Institutions Holding ZTS

# of Institutions
2,060
Shares Held
420M
Call Options Held
1.22M
Put Options Held
1.61M
View Full List

About Zoetis Inc.

ZTS Quotes by TradingView
  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $75.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email